+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin



Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin



ChemoTherapy 51(2-3): 80-85



The in vitro activity of two new expanded spectrum fourth-generation cephalosporins, cefepime and cefpirome, was compared with that of five antibacterial agents, ceftazidime, cefoperazone, cefotaxime, imipenem, and ciprofloxacin, that are commonly used in the treatment of serious infections caused by aerobic gram-negative bacteria. The agar dilution method described by the US National Committee for Clinical Laboratory Standards was used to determine the minimum inhibitory concentrations of antibiotics tested. Three hundred and two clinical isolates, representing a cross-section of Klebsiella and Enterobacter species and Pseudomonas aeruginosa were tested. The most potent beta-lactams were imipenem, cefepime, and cefpirome, which demonstrated significant activity against the majority of strains in all three genera of bacteria, as did ciprofloxacin. Ceftazidime was active against P. aeruginosa, but was less potent against Klebsiella and Enterobacter species. Cefoperazone and cefotaxime were less active than ceftazidime against P. aeruginosa. Cefepime had slightly greater activity than cefpirome against the gram-negative bacteria tested. These data indicate that cefepime and cefpirome are highly active against many frequently resistant nosocomial bacterial strains that are traditionally responsible for difficult-to-treat infections.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012100345

Download citation: RISBibTeXText

PMID: 15870501

DOI: 10.1159/000085614


Related references

Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveillance Group. Diagnostic Microbiology and Infectious Disease 19(2): 111-120, 1994

The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli. Pathology 17(4): 636-639, 1985

In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli. Microbios 84(339): 87-90, 1995

In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance. Antimicrobial Agents and ChemoTherapy 27(5): 817-820, 1985

In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens. Die Pharmazie 59(11): 854-858, 2004

Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units. Diagnostic Microbiology and Infectious Disease 22(3): 285-291, 1995

Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals. Journal of Antimicrobial ChemoTherapy 32(3): 413-419, 1993

Ciprofloxacin bay 09867 comparative activity with beta lactam antibiotics and gentamicin against aerobic gram positive and gram negative bacteria. Abstracts of the Annual Meeting of the American Society for Microbiology 84: ABSTRACT A63, 1984

In vitro effectiveness of mecillinam against gram negative bacilli resistant to beta lactam antibiotics. Abstracts of the Annual Meeting of the American Society for Microbiology (79): 323, 1979

In vitro activity of 1st 2nd and 3rd generation cephalosporins against 900 clinical isolates of gram negative bacilli. Abstracts of the Annual Meeting of the American Society for Microbiology 83: A9, 1983

The In Vitro Activity Of The Newer -Lactam Antibiotics Against 124 Strains Of Gram-Negative Bacilli. Pathology 17(4): 636-639, 1985

In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients. Indian Journal of Cancer 31(1): 23-26, 1994

In vitro activity of BL-s640 against gram-negative bacilli and Staphylococcus aureus compared with activity of four other semisynthetic cephalosporins. Antimicrobial Agents and ChemoTherapy 9(3): 422-432, 1976

Comparative studies of in vitro activity of piperacillin and 3rd generation cephalosporins against gram negative bacilli and streptococcus faecalis. Abstracts of the Annual Meeting of the American Society for Microbiology 84: ABSTRACT A33, 1984

Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli. Reviews of Infectious Diseases 4 Suppl: S401-S405, 1982